'Tumor antigens' presentation slideshows

Tumor Immunology Tumor antigen Tumor immune escape Qingqing Wang Institute of Immunology, ZJU

Tumor Immunology Tumor antigen Tumor immune escape Qingqing Wang Institute of Immunology, ZJU wqq@zju.edu.cn. Contents. Concept of immune surveillance Tumor antigens Immune mechanisms of tumor rejection Evasion of immune responses by tumors Immunotherapy for cancers.

753 views • 73 slides

Tumor Immunology Tumor antigen Tumor immune escape Qingqing Wang wqq@zju

Tumor Immunology Tumor antigen Tumor immune escape Qingqing Wang wqq@zju.edu.cn. Contents. Concept of immune surveillance Tumor antigens Immune mechanisms of tumor rejection Evasion of immune responses by tumors Immunotherapy for cancers.

1.47k views • 71 slides

Chapter 20 Tumor Immunology

Chapter 20 Tumor Immunology. Contents. Introduction Part? Tumor antigens Part? Immune response to tumors Part ? Mechanism of tumor escape from immune surveillance Part? Immunotherapy of tumors. Introduction.

1.18k views • 60 slides

Tumor Immunology Tumor antigen Tumor immune escape Qingqing Wang wqq@zju

Tumor Immunology Tumor antigen Tumor immune escape Qingqing Wang wqq@zju.edu.cn. Contents. Concept of immune surveillance Tumor antigens Immune mechanisms of tumor rejection Evasion of immune responses by tumors Immunotherapy for cancers.

980 views • 59 slides

Chapter 20 Tumor Immunology

Chapter 20 Tumor Immunology. Contents. Part ? Introduction Part ? Tumor antigens Part ? Immune response to tumors Part ? Mechanism of tumor escape from immune surveillance Part ? Immunotherapy of tumors. Part? Introduction. Tumor immunology

1.92k views • 51 slides

Medical Immunology

Medical Immunology. Department of Immunology. Yiwei Chu. Chapter 17. Immunity to tumors. June, 21, 2010. Content. 1. General Features. 2. Tumor antigen. 3. Immune Responses. 4. Evasion of Immune Responses. 5. Immunotherapy.

676 views • 48 slides

Cross-presentation

582 views • 44 slides

Introduction of Tumor Immunology

Introduction of Tumor Immunology. Bei-Chang Yang ( ??? ) , Ph.D. Department of Microbiology & Immunology ext 5637; y1357@mail.ncku.edu.tw Pin Ling ( ? ? ), Ph.D. ext 5632; lingpin@mail.ncku.edu.tw References: 1. Tumor Immunology and Cancer Vaccines

850 views • 44 slides

Tumor Immunology

Tumor Immunology. Masoud H. Manjili Department of Microbiology & Immunology Goodwin Research Laboratory-286 Tel# (804) 828-8779. Learning Objectives. Etiology of cancer Mechanisms by which immune system recognize tumors Understand tumor escape mechanisms

1.08k views • 28 slides

Immune response against tumors

469 views • 19 slides

Immune response against tumors

637 views • 19 slides

Immune response against tumors

375 views • 19 slides

303 views • 18 slides

New therapeutic approaches in lung cancer

New therapeutic approaches in lung cancer. Dr Marc Lambrechts. Anti-cancer strategies for NSCLC today. Traditional therapies. Targeted therapies. Adjuvant chemotherapy improves survival in early stage NSCLC. Addition of targeted therapies to 1 st -line chemotherapy.

335 views • 14 slides

Why Use Intra-Tumoral Immunotherapy with Immuno-Modulator Compounds

Intra-tumoral Immunotherapy is its ability to avoid administering standard conventional cancer treatment protocols (e.g. Surgery, radiation and/or chemotherapy) in exchange for a minimally-invasive procedure with no side effects, and to benefit from newer immuno-modulator compounds.

150 views • 14 slides

Radioimmunotherapy

1.2k views • 12 slides

Cancer immunology and immunotherapy

389 views • 11 slides

A Timeline of Pioneering Cancer Treatments

384 views • 1 slides

Tumor immunity

Tumor immunity: http://www.creative-diagnostics.com/Tumor-Immunity.htm

75 views • 1 slides

Tumor Immunity

The existence of immune surveillance has been demonstrated by the increased incidence of some types of tumors in immunocompromised experimental animals and humans. It is now clear that the innate and adaptive immune systems do react against many tumors, and exploiting these reactions to specifically destroy tumors remains an important goal of tumor immunologists.

12 views • 1 slides